Search
Feed aggregator
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Early NSCLC 4/19/2024
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring
Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring 4/19/2024
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations? 4/19/2024
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies 4/19/2024
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market 4/18/2024
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win 4/18/2024
Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition
Cerevel Gets Phase III Parkinson’s Win on Heels of $8.7B AbbVie Acquisition 4/18/2024
Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA
Most Doses of Lilly’s Zepbound and Mounjaro in Short Supply Through Q2: FDA 4/18/2024
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch 4/18/2024
Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS
Roche’s Ocrevus Achieves Near-Complete Reduction of Relapse, Lesions in MS 4/18/2024
Bioversity Program Preps Grads for Early-Career Life Science Roles
Bioversity Program Preps Grads for Early-Career Life Science Roles 4/18/2024
How to Deal With Layoff-Related Stress
How to Deal With Layoff-Related Stress 4/18/2024
Career Coach: How to Look Professional in Virtual Meetings
Career Coach: How to Look Professional in Virtual Meetings 4/18/2024
5 Top Companies Hiring Oncology Jobs
5 Top Companies Hiring Oncology Jobs 4/18/2024
Lilly Eyes Zepbound Label Expansion After Clearing Phase III Sleep Apnea Study
Lilly Eyes Zepbound Label Expansion After Clearing Phase III Sleep Apnea Study 4/17/2024
Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop
Sage Axes Parkinson’s Program for Dalzanemdor After Phase II Flop 4/17/2024
Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS
Amylyx Sheds More Light on Relyvrio’s Late-Stage Trial Failure in ALS 4/17/2024
Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio?
Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio? 4/17/2024
Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space
Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space 4/17/2024
Top Q1 Series A Investments Highlight VC Rebound in Biopharma
Top Q1 Series A Investments Highlight VC Rebound in Biopharma 4/17/2024
World Pharma News
- U.S. FDA grants full approval to Pfizer's BRAFTOVI combination regimen in first-line metastatic colorectal cancer
- New antibody-drug conjugate strategy to block HIV infection
- Rhododendron-derived drugs now made by bacteria
- Lung cancer drug offers a surprising new treatment against ovarian cancer
- Researchers identify promising Alzheimer's disease drug target